This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (December 2018) (Learn how and when to remove this template message)
|Founders||John Abele, Founder & Director Emeritus |
Peter Nicholas, Founder & Director Emeritus
|Headquarters||Marlborough, Massachusetts, United States|
|Michael F. Mahoney, Chairman and (CEO) |
Daniel Brennan, CFO
|Revenue||$10.74 billion (2019)|
|$1.51 billion (2019)|
|$4.70 billion (2019)|
|Total assets||$30.57 billion (2019)|
|Total equity||$13.88 billion (2019)|
Number of employees
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Boston Scientific is primarily known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD).